Ballentine Partners’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,262
| Closed | -$333K | – | 1006 |
|
|
2025
Q1 | $333K | Sell |
2,262
-346
| -13% | -$52.8K | 0.01% | 587 |
|
|
2024
Q4 | $424K | Buy |
2,608
+134
| +5% | +$21.9K | 0.01% | 472 |
|
|
2024
Q3 | $403K | Buy |
2,474
+288
| +13% | +$42.7K | 0.01% | 487 |
|
|
2024
Q2 | $298K | Sell |
2,186
-520
| -19% | -$72.2K | 0.01% | 563 |
|
|
2024
Q1 | $414K | Buy |
2,706
+379
| +16% | +$56.6K | 0.01% | 442 |
|
|
2023
Q4 | $332K | Buy |
2,327
+720
| +45% | +$96K | 0.01% | 475 |
|
|
2023
Q3 | $211K | Sell |
1,607
-519
| -24% | -$78.9K | 0.01% | 541 |
|
|
2023
Q2 | $338K | Buy |
2,126
+240
| +13% | +$38.7K | 0.01% | 422 |
|
|
2023
Q1 | $298K | Buy |
1,886
+434
| +30% | +$65.1K | 0.01% | 418 |
|
|
2022
Q4 | $204K | Sell |
1,452
-218
| -13% | -$30.9K | 0.01% | 463 |
|
|
2022
Q3 | $215K | Sell |
1,670
-82
| -5% | -$11.8K | 0.01% | 421 |
|
|
2022
Q2 | $248K | Sell |
1,752
-785
| -31% | -$112K | 0.01% | 358 |
|
|
2022
Q1 | $352K | Buy |
2,537
+260
| +11% | +$39.8K | 0.01% | 320 |
|
|
2021
Q4 | $397K | Buy |
2,277
+504
| +28% | +$84K | 0.01% | 317 |
|
|
2021
Q3 | $294K | Buy |
1,773
+413
| +30% | +$71.1K | 0.01% | 317 |
|
|
2021
Q2 | $245K | Buy |
1,360
+155
| +13% | +$28.3K | 0.01% | 361 |
|
|
2021
Q1 | $233K | Sell |
1,205
-13
| -1% | -$2.5K | 0.01% | 349 |
|
|
2020
Q4 | $246K | Sell |
1,218
-102
| -8% | -$21.1K | 0.01% | 326 |
|
|
2020
Q3 | $277K | Sell |
1,320
-1,214
| -48% | -$270K | 0.01% | 307 |
|
|
2020
Q2 | $556K | Sell |
2,534
-319
| -11% | -$63.7K | 0.03% | 200 |
|
|
2020
Q1 | $495K | Buy |
2,853
+73
| +3% | +$12.1K | 0.03% | 189 |
|
|
2019
Q4 | $427K | Sell |
2,780
-5
| -0.2% | -$747 | 0.02% | 242 |
|
|
2019
Q3 | $423K | Buy |
2,785
+191
| +7% | +$30.2K | 0.02% | 235 |
|
|
2019
Q2 | $396K | Buy |
+2,594
| New | +$396K | 0.02% | 244 |
|
Other funds holding CLX
